Prolotherapy with 25% dextrose for pain management in patients with plantar fasciitis
DOI:
https://doi.org/10.58814/01208845.91Keywords:
Plantar Fasciitis, Prolotherapy, Pain ManagementAbstract
Introduction: Plantar fasciitis (PF) is a common cause of heel pain in adults. Prolotherapy is one of the possible therapeutic options to treat this condition.
Objective: To determine the efficacy of prolotherapy with 25% dextrose in reducing the level of pain in patients with PF.
Methodology: Retrospective observational cohort study performed in 70 patients with PF who underwent prolotherapy with 25% dextrose in a medical institution in Colombia in 2021. The level of pain with the foot at rest was measured using the visual analog scale (VAS) during each prolotherapy session, which took place at 0, 1, 4, 7, 10, and 13 months. Analysis of variance (ANOVA) was performed by means of Friedman test and multivariate analysis by means of linear mixed models to determine the association between variables.
Results: A total of 245 prolotherapy sessions were performed. The mean age of the patients was 53 years and 80% of them were female. The median VAS scores were 9, 8, 6, 5, 4, and 2 in the 6 prolotherapy sessions, respectively. A progressive decrease in pain was observed throughout the treatment; however, statistically significant differences were only found between the first and third sessions (p<0.05).
Conclusions: Prolotherapy with 25% dextrose showed good results since the level of foot pain at rest decreased progressively, especially between the first and third sessions.
Downloads
References
Wearing SC, Smeathers JE, Urry SR, Hennig EM, Hills AP. The Pathomechanics of Plantar Fasciitis. Sports Med. 2006;36(7):585-611, https://doi.org/d23qzw.
Buchbinder R. Clinical Practice. Plantar Fasciitis. N Engl J Med. 2004;350(21):2159-66. https://doi.org/fqv2qb.
Thomas M.J, Roddy E, Zhang W, Menz H.B, Hannan M.T, Peat GM. The Population Prevalence of Foot and Ankle Pain in Middle and Old Age: A Systematic Review. Pain. 2011;152(12):2870-80. https://doi.org/frmx5n.
Raissi G, Arbabi A, Rafiei M, Forogh B, Babaei-Ghazani A, Khalifeh Soltani S, et al. Ultrasound-Guided Injection of Dextrose Versus Corticosteroid in Chronic Plantar Fasciitis Management: A Randomized, Double-Blind Clinical Trial. Foot Ankle Spec. 2021;16(1):9-19. https://doi.org/k382.5. Thomas JL, Christensen JC, Kravitz SR, Mendicino RW, Schuberth JM, Vanore JV, et al. The Diagnosis and Treatment of Heel Pain: A Clinical Practice Guideline-Revision 2010. J Foot Ankle Surg. 2010;49 (Suppl. 3),S1-S19.https://doi.org/cbwkrx.
Radwan A, Wyland M, Applequist L, Bolowsky E, Klingensmith H, Virag I. Ultrasonography, an effective tool in diagnosing plantar fasciitis: a systematic review of diagnostic trials. Int J Sports Phys Ther. 2016;11(5),663-71.
Menz HB, Dufour AB, Casey VA, Riskowski JL, McLean RR, Katz P, et al. Foot Pain and Mobility Limitations in Older Adults: The Framingham Foot Study. J Gerontol A Biol Sci Med Sci. 2013;68(10):1281-., https://doi.org/f5b752.
Urits I, Smoots D, Franscioni H, Patel A, Fackler N, Wiley S, et al. Injection Techniques for Common Chronic Pain Conditions of the Foot: A Comprehensive Review. Pain Ther. 2020;9(1):145-60. https://doi.org/gmdzgm.
Johal KS, Milner SA. Plantar Fasciitis and the Calcaneal Spur: Fact or Fiction? Foot Ankle Surg. 2012;18(1):39-41. https://doi.org/d8h74d.
Mahindra P, Yamin M, Selhi HS, Singla S, Soni A. Chronic Plantar Fasciitis: Effect of Platelet-Rich Plasma, Corticosteroid, and Placebo. Orthopedics. 2016;39(2):e285-e289. https://doi.org/f8rgmk.
Ricci V, Özçakar L. Ultrasonographic Examination: The “X-Factor” in Physiatry. Am J Phys Med Rehabil. 2020;99(11):e131-e132. https://doi.org/k383.
Uğurlar M, Sönmez MM, Uğurlar ÖY, Adıyeke L, Yıldırım H, Eren OT. Effectiveness of Four Different Treatment Modalities in the Treatment of Chronic Plantar Fasciitis During a 36-Month Follow-Up Period: A Randomized Controlled Trial. J Foot Ankle Surg. 2018;57(5):913-18. https://doi.org/gd7ntx.
Kesikburun S, Uran Şan A, Kesikburun B, Aras B, Yaşar E, Tan AK. Comparison of Ultrasound-Guided Prolotherapy Versus Extracorporeal Shock Wave Therapy in the Treatment of Chronic Plantar Fasciitis: A Randomized Clinical Trial. J Foot Ankle Surg. 2022;61(1):48-52. https://doi.org/k384.
Asheghan M, Hashemi SE, Hollisaz MT, Roumizade P, Hosseini SM, Ghanjal A. Dextrose Prolotherapy versus Radial Extracorporeal Shock Wave Therapy in the Treatment of Chronic Plantar Fasciitis: A Randomized, Controlled Clinical Trial. Foot Ankle Surg. 2021;27(6):643-49. https://doi.org/k385.
Mansiz-Kaplan B, Nacir B, Pervane-Vural S, Duyur-Cakit, B, Genc H. Effect of Dextrose Prolotherapy on Pain Intensity, Disability, and Plantar Fascia Thickness in Unilateral Plantar Fasciitis: A Randomized, Controlled, Double-Blind Study. Am J Phys Med Rehabil. 2020;99(4):318–24. https://doi.org/gk3x8b.
Kim E, Lee JH. Autologous Platelet-Rich Plasma versus Dextrose Prolotherapy for the Treatment of Chronic Recalcitrant Plantar Fasciitis. PM R. 2014;6(2):152-58. https://doi.org/k386.
Tiwari M, Bhargava R. Platelet Rich Plasma Therapy: A Comparative Effective Therapy with Promising Results in Plantar Fasciitis. J Clin Orthop Trauma. 2013;4(1):31-5. https://doi.org/k387.
Lai W-F, Yoon CH, Chiang MT, Hong Y-H, Chen H-C, Song W, et al.The Effectiveness of Dextrose Prolotherapy in Plantar Fasciitis: A Systemic Review and Meta-Analysis. Medicine (Baltimore). 2021;100(51):e28216. https://doi.org/k388.
Chung M-W, Hsu C-Y, Chung W-K, Lin Y-N. Effects of Dextrose Prolotherapy on Tendinopathy, Fasciopathy, and Ligament Injuries, Fact or Myth?: A Systematic Review and Meta-Analysis. Medicine (Baltimore). 2020;99(46):e23201. https://doi.org/k389.
Chutumstid T, Susantitaphong P, Koonalinthip N. Effectiveness of Dextrose Prolotherapy for the Treatment of Chronic Plantar Fasciitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PM R. 2022;15(3):380-91. https://doi.org/k4b6.
Ryan MB, Wong AD, Gillies JH, Wong J, Taunton JE. Sonographically Guided Intratendinous Injections of Hyperosmolar Dextrose/Lidocaine: A Pilot Study for the Treatment of Chronic Plantar Fasciitis. Br J Sports Med. 2009;43(4):303-06. https://doi.org/dq5j8c.
Van Schaik KD, Lee KS. Orthobiologics: Diagnosis and Treatment of Common Tendinopathies. Semin. Musculoskelet. Radiol. 2021;25(6):735-44. https://doi.org/k4b7.
Ekwueme EC, Mohiuddin M, Yarborough JA, Brolinson PG, Docheva D, Fernandes HAM, et al. Prolotherapy Induces an Inflammatory Response in Human Tenocytes In Vitro. Clin Orthop Relat ResClin. Orthop. 2017;475(8):2117-27. https://doi.org/gbnq9x.
Jensen KT, Rabago DP, Best TM, Patterson JJ, Vanderby R. Early Inflammatory Response of Knee Ligaments to Prolotherapy in a Rat Model. J Orthop Res. 2008;26(6):816-23. https://doi.org/fxckjx.
Di Paolo S, Gesualdo L, Ranieri E, Grandaliano G, Schena FP. High Glucose Concentration Induces the Overexpression of Transforming Growth Factor-Beta through the Activation of a Platelet-Derived Growth Factor Loop in Human Mesangial Cells. Am J Pathol. 1996;149(6):2095-106.
Strauchman MN, Morningstar MW. Prolotherapy Injections for Diastasis Recti: A Case Report. Case Rep Clin Med. 2016;5(9);342–6, https://doi.org/k4b9.
Tatli YZ, Kapasi S. The Real Risks of Steroid Injection for Plantar Fasciitis, with a Review of Conservative Therapies. Curr Rev Musculoskelet Med. 2009;2(1):3-9. https://doi.org/csj52r.
Díaz-Llopis IV, Rodríguez-Ruíz CM, Mulet-Perry S, Mondéjar-Gómez FJ, Climent-Barberá JM, Cholbi-Llobel F. Randomized Controlled Study of the Efficacy of the Injection of Botulinum Toxin Type A versus Corticosteroids in Chronic Plantar Fasciitis: Results at One and Six Months. Clin Rehabil. 2012;26(7):594-606. https://doi.org/dmkjx6.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Revista Colombiana de ortopedia y traumatología
This work is licensed under a Creative Commons Attribution 3.0 Unported License.
Derechos de autor
Los autores aceptar transferir a la Revista Colombiana de Ortopedia y Traumatología los derechos edición, publicación y reproducción de los artículos publicados. La editorial tiene el derecho del uso, reproducción, transmisión, distribución y publicación en cualquier forma o medio. Los autores no podrán permitir o autorizar el uso de la contribución sin el consentimiento escrito de la revista. Una vez firmada por todos los autores, la carta de Cesión de derechos debe ser cargada en el paso dos del envío.
Aquellos autores que tengan publicaciones en esta revista aceptan los siguientes términos:
- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
- Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web), lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).
